*ST天山(300313.SZ):控股股東所持部分股份公開拍賣 公司控制權或將發生變更
格隆匯7月18日丨*ST天山(300313.SZ)公佈,公司於2025年7月18日收到公司控股股東湖州皓輝企業管理諮詢有限公司(簡稱“湖州皓輝”)發來的《告知書》,湖州皓輝和湖州中植融雲投資有限公司(簡稱“湖州中植”)於2025年7月18日在京東資產交易平臺發佈競買公告,將湖州皓輝持有的53,861,312股公司股票和湖州中植對公司享有的7,649萬元債權及項下權益進行公開拍賣。截至公告日,本次拍賣相關的競買公告已在京東資產交易平臺上發佈。
若本次拍賣成功,將可能導致公司控制權發生變更。敬請廣大投資者審慎決策,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.